BRIEF published on 10/29/2024 at 14:49, 22 days 22 hours ago Trigano to Acquire BIO Habitat Acquisition Trigano European Market BIO Habitat Mobile Homes
REGULATED PRESS RELEASE published on 10/29/2024 at 14:44, 22 days 23 hours ago Acquisition of BIO Habitat Trigano receives clearance to acquire BIO Habitat, consolidating its position in the European leisure vehicle industry. Acquisition expected to close by end of 2024 Acquisition Trigano European Market Leisure Vehicles BIO Habitat
BRIEF published on 09/26/2024 at 17:50, 1 month 24 days ago Trigano Achieves Record Sales in 2023/2024 Fiscal Year Motorhome Market European Market Record Sales Supply Chain Improvement ElectriX Launch
REGULATED PRESS RELEASE published on 09/26/2024 at 17:45, 1 month 24 days ago 2023/2024 Sales Trigano reports record sales of 3.9 billion Euros (+12.8%) for 2023/24, driven by motorhome business (+21.7%) in buoyant market. Strong performance in leisure vehicles despite lower demand in other categories Trigano Financial Year Record Sales Leisure Vehicles Motorhome Business
BRIEF published on 06/24/2024 at 18:39, 4 months 26 days ago Trigano Achieves 10.8% Sales Growth in Q3 2023/2024 Sales Europe Growth Market Motorhomes
REGULATED PRESS RELEASE published on 06/24/2024 at 18:34, 4 months 26 days ago 2023/2024 Third Quarter Sales Trigano's 2023/2024 Third Quarter Sales reach €1,146.2M, showing a 10.8% increase, driven by motorhome sales growth. Market outlook remains positive Trigano European Market Third Quarter Sales Market Growth Motorhome Sales
BRIEF published on 05/14/2024 at 17:50, 6 months 6 days ago Trigano Reports Strong Growth in First Half-Year Results of 2023/2024 Dividend Payments Market Outlook Trigano Financial Results Leisure Vehicle Sales Corporate Investments
REGULATED PRESS RELEASE published on 05/14/2024 at 17:45, 6 months 6 days ago 2023/2024 First Half-Year Results Trigano reports a 40.3% increase in consolidated operating profit for the first half of 2024, driven by motorhome sales growth and cost control measures Financial Results Trigano Operating Profit Cost Control Motorhome Sales
ARTICLE published on 03/27/2024 at 19:03, 7 months 24 days ago Trigano: turnover up 18.4% in the first half of 2023/2024 Trigano achieved a turnover of €1.9 billion in the first half of 2023/2024, up 18.4% Trigano Turnover Motorhomes Caravans Trailers
BRIEF published on 03/27/2024 at 17:45, 7 months 24 days ago Trigano posts robust growth in the first half of 2023/2024 Trigano European Market Turnover Motorhomes Caravans
Published on 11/21/2024 at 13:30, 15 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 15 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 45 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 45 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 45 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 10 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 30 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
